Gilstrap LG, Vest AR. How Do I Optimize Heart Failure Medications for Patients with Hypotension or Chronic Kidney Disease?
NEJM EVIDENCE 2022;
1:EVIDccon2200084. [PMID:
38319838 DOI:
10.1056/evidccon2200084]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
HF Medications for Hypotension or CKDThe cornerstone of treatment for HF with reduced ejection fraction is GDMT; however, safely delivering maximal therapy is often hampered by low blood pressure, labile renal function, or both. Reviewing the physiologic basis of GDMT and exploring each drug's mechanism of action and unique properties can enable careful initiation and titration of therapy, even in patients with hypotension or CKD.
Collapse